Processing of Notch and amyloid precursor protein by γ-secretase is spatially distinct

  1. Leonid Tarassishin,
  2. Ye Ingrid Yin,
  3. Bhramdeo Bassit, and
  4. Yue-Ming Li*
  1. Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
  1. Communicated by Thomas J. Kelly, Sloan-Kettering Institute, New York, NY, October 27, 2004 (received for review July 12, 2004)

Abstract

γ-Secretase activity is associated with a presenilin (PS)-containing macromolecular complex. Whether PS contains the active site of γ-secretase has been controversial. One challenge is to find PS that is engaged in the active γ-secretase complex at the cell surface, where some substrates appear to be processed. In this study, we developed an intact cell photolabeling technique that allows the direct visualization of active γ-secretase at the cell surface. We demonstrated that active γ-secretase is present in the plasma membrane. Moreover, the PS1 heterodimer is specifically photolabeled at the cell surface by a potent inhibitor that binds to only the active γ-secretase. We also explored the cellular processing sites of γ-secretase for amyloid precursor protein (APP) and Notch by using small molecular probes. MRL631, a γ-secretase inhibitor that is unable to penetrate the cell membrane, significantly blocks γ-secretase-mediated Notch cleavage but has little effect on APP processing. These results indicate that Notch is processed at the cell surface and that the majority of APP is processed by intracellular γ-secretase. Furthermore, the fact that inhibitors first target γ-secretase in the plasma membrane for Notch processing, and not for APP, will have important implications for drug development to treat Alzheimer's disease and cancer.

Footnotes

  • * To whom correspondence should be addressed. E-mail: liy2{at}mskcc.org.

  • Author contributions: L.T. and Y.-M.L. designed research; L.T., Y.I.Y., and B.B. performed research; L.T. and Y.I.Y. analyzed data; and Y.-M.L. wrote the paper.

  • Abbreviations: AD, Alzheimer's disease; APP, amyloid precursor protein; PS, presenilin; NTF, N-terminal fragment; CTF, C-terminal fragment; SLO, streptolysin-O; WGA, wheat germ agglutinin; Aβ, β-amyloid.

« Previous | Next Article »Table of Contents